CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Durect Corporation Company Snapshot
Durect Corporation operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Durect with three other companies in this sector in the United States: AcelRx Pharmaceuticals Inc (2015 sales of $19.26 million of which 100% was Innovative Therapies), Relypsa Inc ($18.55 million of which 100% was Biopharmaceuticals), and Aveo Pharmaceuticals, Incorporation. ($19.02 million of which 100% was Cancer Therapeutics).

Sales Analysis. Durect reported sales of $19.12 million for the year ending December of 2015. This represents a decrease of 1.4% versus 2014, when the company's sales were $19.40 million.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Durect Corporation
  Stock Performance Chart for Durect Corporation
 
  Stock Data: Recent Stock Performance:
  Current Price (12/2/2016): 1.25
(Figures in U.S. Dollars)
1 Week -9.4%   13 Weeks 10.6%  
4 Weeks -24.7%   52 Weeks -50.8%  
 
Durect Corporation Key Data:
  Ticker: DRRX Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2015 Sales 19,124,000
(Year Ending Jan 2016).
Employees: 106
  Currency: U.S. Dollars Market Cap: 173,226,945
  Fiscal Yr Ends: December Shares Outstanding: 138,581,556
  Share Type: Common Closely Held Shares: 12,691,429
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.